CCHF Symposium: Chemistry in the Pharmaceutical Industry

On Wednesday, January 10th, the Center for Selective C-H Functionalization (CCHF) hosted ‘Chemistry in the Pharmaceutical Industry’, a symposium organized to celebrate chemistry in the pharmaceutical sciences. The event featured speakers across academia and industry to provide a comprehensive view of some recent advances in the pharmaceutical field.

Speakers included:

James Mousseau of Pfizer Inc.

“Leveraging Industrial/Academic Collaborations to Increase Access of New 3-Dimensional Architectures”


Kaid Harper of AbbVie Inc.

“Scaling Photoredox Catalysis in Flow”


Duncan Shaw of Novartis Institutes for Biomedical Research

“Designing PDGFR inhibitors for duration of action after inhaled delivery”


Jaume Balsells-padros of Merck & Co., Inc.

“Radical Conjugate addition of alkyl bromides to α,β-unsaturated amides and esters via photoredox catalysis”


Scott Miller of Yale University

“Catalytic Site- and Enantioselective Electrophillic Aromatic Substitutions”


The lectures were followed by a poster session during which new advances in the field were presented and discussed.